Why the study?
Do screening instruments improve the recognition of depressive disorders in older adults?
Do screening instruments improve the recognition of depressive disorders in older adults?
This review highlights the utility of various screening instruments for improving the recognition of depressive disorders in older adults.
May support screening consideration in older adults; leaves open effects on clinical outcomes without prospective trials.
The prevalence of clinically significant depressive disorders in persons 65 years of age or older in the United States has been estimated to be approximately 15%, increasing the risk for functional decline, morbidity, and mortality. Utilization of a well-chosen screening instrument has been shown to improve the rates of recognition of depressive disorders in older adults. This paper presents a targeted review of the most commonly accepted tools for case-finding of depressive disorders in older adults. After a review of the benefits and shortcomings of screening tools, the strengths, weaknesses, and utility of selected depression scales in geriatric clinical settings are discussed.
No takes yet. Share an insight, caveat, or question.
Roman et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: